Jim Simons Atai Life Sciences N.V. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.17 - $2.7 $670,527 - $1.55 Million	573,100 New	573,100 $1.04 Million
Q3 2022 Nov 14, 2022	SELL	$3.14 - $4.87 $564,886 - $876,113	-179,900 Reduced 42.01%	248,300 $822,000
Q2 2022 Aug 12, 2022	BUY	$3.03 - $5.32 $90,772 - $159,376	29,958 Added 7.52%	428,200 $1.56 Million
Q1 2022 May 13, 2022	BUY	$4.66 - $7.66 $648,867 - $1.07 Million	139,242 Added 53.76%	398,242 $2.03 Million
Q4 2021 Feb 11, 2022	BUY	$6.82 - $17.8 $1.77 Million - $4.61 Million	259,000 New	259,000 $1.98 Million

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.